AstraZeneca in partnering talks for Alzheimer drug

[Reuters – UK Focus] – AstraZeneca, fighting a $106 billion bid approach from Pfizer, is talking to other companies as it seeks a partnering deal for its experimental Alzheimer’s drug. Briggs Morrison, global head of medicines … more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard

See who Astrazeneca is hiring next, click here to view